210 related articles for article (PubMed ID: 22498805)
1. Hypomagnesemia in type 2 diabetic nephropathy: a novel predictor of end-stage renal disease.
Sakaguchi Y; Shoji T; Hayashi T; Suzuki A; Shimizu M; Mitsumoto K; Kawabata H; Niihata K; Okada N; Isaka Y; Rakugi H; Tsubakihara Y
Diabetes Care; 2012 Jul; 35(7):1591-7. PubMed ID: 22498805
[TBL] [Abstract][Full Text] [Related]
2. Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E; Lambers Heerspink HJ; Lutgers HL; Bakker SJ; Vart P; Wolffenbuttel BH; Umanath K; Lewis JB; de Zeeuw D; Gansevoort RT
Am J Kidney Dis; 2015 Sep; 66(3):450-8. PubMed ID: 25987260
[TBL] [Abstract][Full Text] [Related]
3. Diabetes Control and the Risks of ESRD and Mortality in Patients With CKD.
Navaneethan SD; Schold JD; Jolly SE; Arrigain S; Winkelmayer WC; Nally JV
Am J Kidney Dis; 2017 Aug; 70(2):191-198. PubMed ID: 28196649
[TBL] [Abstract][Full Text] [Related]
4. Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy.
Yamanouchi M; Hoshino J; Ubara Y; Takaichi K; Kinowaki K; Fujii T; Ohashi K; Mise K; Toyama T; Hara A; Kitagawa K; Shimizu M; Furuichi K; Wada T
PLoS One; 2018; 13(1):e0190930. PubMed ID: 29338014
[TBL] [Abstract][Full Text] [Related]
5. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).
Haynes R; Staplin N; Emberson J; Herrington WG; Tomson C; Agodoa L; Tesar V; Levin A; Lewis D; Reith C; Baigent C; Landray MJ;
Am J Kidney Dis; 2014 Jul; 64(1):40-8. PubMed ID: 24613056
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
Fragoso A; Mendes F; Silva AP; Neves PL
J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
[TBL] [Abstract][Full Text] [Related]
8. Effect of depression on progression to end-stage renal disease or pre-end-stage renal disease death in advanced diabetic nephropathy: A prospective cohort study of the Diabetes Study from the Center of Tokyo Women's Medical University.
Horiba Y; Ishizawa K; Takasaki K; Miura J; Babazono T
J Diabetes Investig; 2022 Jan; 13(1):94-101. PubMed ID: 34174034
[TBL] [Abstract][Full Text] [Related]
9. The effect of continuity of care on the incidence of end-stage renal disease in patients with newly detected type 2 diabetic nephropathy: a retrospective cohort study.
Jang YJ; Choy YS; Nam CM; Moon KT; Park EC
BMC Nephrol; 2018 Jun; 19(1):127. PubMed ID: 29871604
[TBL] [Abstract][Full Text] [Related]
10. Combined diabetes-renal multifactorial intervention in patients with advanced diabetic nephropathy: Proof-of-concept.
Fogelfeld L; Hart P; Miernik J; Ko J; Calvin D; Tahsin B; Adhami A; Mehrotra R; Fogg L
J Diabetes Complications; 2017 Mar; 31(3):624-630. PubMed ID: 28041817
[TBL] [Abstract][Full Text] [Related]
11. Serum transferrin predicts end-stage Renal Disease in Type 2 Diabetes Mellitus patients.
Zhao L; Zou Y; Zhang J; Zhang R; Ren H; Li L; Guo R; Zhang J; Liu F
Int J Med Sci; 2020; 17(14):2113-2124. PubMed ID: 32922172
[No Abstract] [Full Text] [Related]
12. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy.
Mohanram A; Zhang Z; Shahinfar S; Keane WF; Brenner BM; Toto RD
Kidney Int; 2004 Sep; 66(3):1131-8. PubMed ID: 15327408
[TBL] [Abstract][Full Text] [Related]
13. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
Pavkov ME; Bennett PH; Knowler WC; Krakoff J; Sievers ML; Nelson RG
JAMA; 2006 Jul; 296(4):421-6. PubMed ID: 16868300
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.
Zhao L; Ren H; Zhang R; Wang T; Zou Y; Xu H; Li L; Cooper ME; Liu F
Int Urol Nephrol; 2021 Jun; 53(6):1161-1170. PubMed ID: 33389518
[TBL] [Abstract][Full Text] [Related]
15. Hypomagnesaemia: a modifiable risk factor of diabetic nephropathy.
Bherwani S; Jibhkate SB; Saumya AS; Patel SK; Singh R; Ghotekar LH
Horm Mol Biol Clin Investig; 2017 Mar; 29(3):79-84. PubMed ID: 27416617
[TBL] [Abstract][Full Text] [Related]
16. Association of reduced red blood cell deformability and diabetic nephropathy.
Brown CD; Ghali HS; Zhao Z; Thomas LL; Friedman EA
Kidney Int; 2005 Jan; 67(1):295-300. PubMed ID: 15610255
[TBL] [Abstract][Full Text] [Related]
17. The rate of progression of type 2 diabetes mellitus to end stage renal disease - A single centred retrospective study from Malaysia.
Ng YP; Ahmed R; Ooi GS; Lau CY; Balasubramanian GP; Yap CH
Diabetes Metab Syndr; 2018 Nov; 12(6):1025-1030. PubMed ID: 30168425
[TBL] [Abstract][Full Text] [Related]
18. Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.
Provenzano M; Chiodini P; Minutolo R; Zoccali C; Bellizzi V; Conte G; Locatelli F; Tripepi G; Del Vecchio L; Mallamaci F; Di Micco L; Russo D; Heerspink HJL; De Nicola L
Nephrol Dial Transplant; 2020 Jan; 35(1):138-147. PubMed ID: 30053127
[TBL] [Abstract][Full Text] [Related]
19. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J
J Nephrol; 2019 Oct; 32(5):791-802. PubMed ID: 30888644
[TBL] [Abstract][Full Text] [Related]
20. Association between atherosclerotic cardiovascular diseases risk and renal outcome in patients with type 2 diabetes mellitus.
Ren H; Zhao L; Zou Y; Wang Y; Zhang J; Wu Y; Zhang R; Wang T; Wang J; Zhu Y; Guo R; Xu H; Li L; Cooper ME; Liu F
Ren Fail; 2021 Dec; 43(1):477-487. PubMed ID: 33685340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
